|
|
211 Warren Street Suite 213 Newark, NJ 07102 USA phone:(973) 866-3015 ext 9 fax:(973) 643-4502
|
|
| Symbol |
Private |
| Founded |
2000 |
| Employees |
|
|
|
| www.neurotrax.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Advanced scientific products for assessment of cognitive function. |
 |
| Management |
| Ely Simon |
| |
|
|
| |
|
| Keywords |
| ADD/ADHD, Cognitive assessment, cognitive function, |
|
|
|
| Description |
|
NeuroTrax has designed a computerized system for assessing cognitive health in Mindstreams�. Mindstreams is specially designed to track cognitive performance over time - in the elderly as well as in young people. |
 |
| Products / Services |
The Mindstreams Clinical Edition is a product suite designed for use in patient care to obtain documentation of the patient's cognitive function.
The Mindstreams Cognitive Health Assessment Software is intended to provide clinicians with an objective measurement of cognitive function parameters as an aid in the clinical assessment of cognitive function and suspected cognitive impairment.
An Assessment Report is available within seconds after testing, and contains a complete accounting of performance in the cognitive domains of memory, attention, executive function, visual spatial perception, verbal skills, motor planning, and information processing speed.
|
 |
| Technology / Differentiation |
| The Mindstreams Cognitive Health Assessment Software is intended to provide clinicians with an objective measurement of cognitive function parameters as an aid in the clinical assessment of cognitive function and suspected cognitive impairment.
An Assessment Report is available within seconds after testing, and contains a complete accounting of performance in the cognitive domains of memory, attention, executive function, visual spatial perception, verbal skills, motor planning, and information processing speed. The Mindstreams Cognitive Health Assessment Report results should be interpreted only by qualified professionals. |
 |
| Market / Customers |
mental health professionals and facilities, doctor's offices, any medical professional diagnosing ADHD/ADD and other cognitive disorders requiring medical treatment.
|
 |
| Competitors / Substitutes / Alternatives |
No one else can offer Mindstreams' combination of consistent, objective testing and ease of use for both the medical professional and patient.
|
 |
| Funding |
| The company has raised more than $1.5 million from New Jersey Economic Development Authority (EDA) and private sources. The funding will be used to continue NeuroTrax's growth and expand sales and marketing efforts. |
 |
| Status |
| Pending 510(k); currently not available for sale in the United States but available in International markets. |
 |
|
|
| |
|
|
|
|
|
|